In 2023, the basic pharmaceutical products and preparations manufacturing output in Italy stood at 26.93 billion Euros. Examining trends over the last two years, from 2021 to 2023, there has been a relatively modest year-on-year growth: a 0.6% increase in 2022 and a further 0.49% in 2023. The compound annual growth rate (CAGR) over the past five years was approximately 0.55%, indicating a steady yet slow growth trajectory.

Looking ahead, forecasted data suggest a continuing gradual increase in manufacturing output. By 2028, the output is projected to reach 27.57 billion Euros. The forecasted five-year (2024-2028) CAGR is estimated at 0.37%, reflecting a consistent albeit modest growth rate.

Future trends to watch for include:

Potential impacts of new pharmaceutical regulations and policies.
Technological advancements and innovations in drug manufacturing processes.
Shifts in global demand for pharmaceutical products influenced by demographic changes and health trends.
Economic factors such as inflation, exchange rates, and international trade agreements.